PitchBook

iMediSync Company Profile

iMediSync, founded in 2012 and based in Seoul, South Korea, is a privately held, venture capital-backed company with 15 employees that develops an AI-driven digital mental healthcare platform featuring wireless dry EEG and HRV devices, AI-based brainwave analysis, and biomarker modeling to enable precise brain and heart health assessment and management for clinicians and researchers, operating primarily in diagnostic equipment and health technology sectors with multiple completed funding rounds including Series A, B, and C.

Company Overview

Year Founded: 2012
Status: Private
Employees: 15
Latest Deal Type: Accelerator/Incubator
Investors: 10

General Information

iMediSync is a developer of an AI-driven digital mental healthcare platform designed to advance brain and heart health assessment and management. The company's platform offers wireless dry EEG and HRV measurement devices, AI-based brainwave analysis, and standardized biomarker modeling. This enables clinicians and researchers to diagnose, monitor, and improve mental well-being with precision and efficiency.

Website: www.imedisync.com

Ownership Status: Privately Held (backing)
Financing Status: Venture Capital-Backed

Corporate Office:

  • 411, Teheran-ro, Gangnam-gu
  • 15th Floor, Samseong-dong, Seongdam Building
  • Seoul, 06160
  • South Korea

Primary Industry: Diagnostic Equipment
Other Industries: Other Healthcare Technology Systems

Verticals:

  • LOHAS & Wellness
  • Artificial Intelligence & Machine Learning
  • HealthTech

Valuation & Funding

Deal TypeDateAmountRaised to DateStatusStage
Accelerator/IncubatorCompletedGenerating Revenue
Secondary Transaction - PrivateCompletedGenerating Revenue
Later Stage VC (Series C)03-Feb-2022CompletedGenerating Revenue
Later Stage VC (Series B)01-Apr-2020CompletedGenerating Revenue
Later Stage VC (Series A)01-Jan-2018CompletedGenerating Revenue
Accelerator/Incubator01-Jan-2017CompletedGenerating Revenue
Angel (individual)01-Jan-2017$400K$800KCompletedGenerating Revenue
Seed Round01-Jan-2016$500K$400KCompletedGenerating Revenue

Patents

  • Total Documents (Applications and Grants): 29
  • Total Patent Families: Not specified
  • Granted: 14
  • Pending: 4
  • Expiring in next 12 months: Not specified

Recent Patent Activity

Publication IDPatent TitleStatusFirst Filing DateTechnology (CPC)
WO-2024172440-A1Method, device and computer program for providing therapy through brain wave data analysisInactive14-Feb-2023
US-20250360333-A1Method, device and recording medium for providing therapy through brain wave data analysisPending14-Feb-2023
WO-2024135885-A1Artificial intelligence-based biometric data quality evaluation method, device, and computer program for securing quality-verified biometric dataInactive21-Dec-2022
US-20250253059-A1Digital phenotyping method, apparatus, and computer program for drug response classification and predictionPending25-Oct-2022
WO-2024090640-A1Digital phenotyping method, device, and computer program for drug response classification and predictionInactive25-Oct-2022G16H50/20

Investors (Partial List)

Investor NameInvestor Type
INSPIRACorporation
New England Medical Innovation CenterAccelerator/Incubator
Pathway Partners (Korea)Venture Capital
Withwin InvestmentVenture Capital
A VenturesVenture Capital

FAQs

When was iMediSync founded?

iMediSync was founded in 2012.

Where is iMediSync headquartered?

iMediSync is headquartered in Seoul, South Korea.

What is the size of iMediSync?

iMediSync has 15 total employees.

What industry is iMediSync in?

iMediSync’s primary industry is Diagnostic Equipment.

Is iMediSync a private or public company?

iMediSync is a Private company.

What is iMediSync’s current revenue?

The current revenue for iMediSync is not specified.

How much funding has iMediSync raised over time?

iMediSync has raised $14.3M.

Who are iMediSync’s investors?

INSPIRA, New England Medical Innovation Center, Pathway Partners (Korea), Withwin Investment, and A Ventures are 5 of 10 investors who have invested in iMediSync.